Dr. Susan D. Klugman, MD

Dr. Klugman practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Klugman's NPI, 1649350117, was assigned on October 17, 2006. Dr. Klugman graduated from New York University School of Medicine in 1988. Dr. Klugman holds New York license 184331.

Dr. Klugman's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Klugman's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. Dr. Klugman is also affiliated with White Plains Hospital. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Klugman to 1 more group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klugman practices, 4 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Klugman's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Klugman is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dr. Klugman is licensed in New York.

Dmand AI lists menopause among the conditions Dr. Klugman treats.

CMS data shows 122 Medicare services from Dr. Klugman across 6 procedure codes in 2024, for 90 Medicare patients. Medicare paid $10,661 for them. Every service was in an office.

CMS counts 90 Medicare patients who saw Dr. Klugman in 2024. The largest group is 65 to 74, with 46 patients. 73% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Klugman's median patient age at 38, with 86% women.

In 2024, Dr. Klugman wrote 37 Medicare Part D claims for 17 patients. 97% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $1,089 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Klugman for performance year 2024, reported as part of a group. CMS lists Dr. Klugman as offering telehealth.

Dmand AI links 58 papers to Dr. Klugman, published from 2008 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Prenatal Diagnosis, Genetic Testing and Genetic Counseling. Dr. Klugman has published most often in Genet Med. Dr. Klugman's most frequent co-authors are Tamar Haya Goldwaser, MD, Harry Ostrer, MD and Sabrina Darlene Craigo, MD.

Dmand AI links Dr. Klugman to 1 clinical trial. Conditions studied include Genetic Diseases, Inborn and Congenital, Hereditary, and Neonatal Diseases and Abnormalities.

CMS Open Payments shows 2 general payments to Dr. Klugman from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Myriad Genetic Laboratories, Inc. paid the most, $95.

Dr. Klugman serves on American College of Obstetricians and Gynecologists and American College of Medical Genetics.

Dr. Klugman graduated from New York University School of Medicine in 1988. Dr. Klugman is a member of American College of Medical Genetics, American College of Obstetricians and Gynecologists and American Society of Human Genetics.

Dr. Klugman is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.